- Home
- ALLT vs HUMA Comparison
ALLT vs HUMA Comparison
Compare ALLT & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLT
- HUMA
- Stock Information
- Founded
- ALLT 1996
- HUMA 2004
- Country
- ALLT Israel
- HUMA United States
- Employees
- ALLT N/A
- HUMA N/A
- Industry
- ALLT Telecommunications Equipment
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- ALLT Telecommunications
- HUMA Health Care
- Exchange
- ALLT Nasdaq
- HUMA Nasdaq
- Market Cap
- ALLT 342.5M
- HUMA 250.2M
- IPO Year
- ALLT 2006
- HUMA N/A
- Fundamental
- Price
- ALLT $7.86
- HUMA $1.51
- Analyst Decision
- ALLT Buy
- HUMA Strong Buy
- Analyst Count
- ALLT 1
- HUMA 8
- Target Price
- ALLT N/A
- HUMA $10.88
- AVG Volume (30 Days)
- ALLT 523.8K
- HUMA 5.9M
- Earning Date
- ALLT 08-14-2025
- HUMA 08-11-2025
- Dividend Yield
- ALLT N/A
- HUMA N/A
- EPS Growth
- ALLT N/A
- HUMA N/A
- EPS
- ALLT N/A
- HUMA N/A
- Revenue
- ALLT $95,342,000.00
- HUMA $818,000.00
- Revenue This Year
- ALLT $10.64
- HUMA N/A
- Revenue Next Year
- ALLT $15.76
- HUMA $949.92
- P/E Ratio
- ALLT N/A
- HUMA N/A
- Revenue Growth
- ALLT 4.74
- HUMA N/A
- 52 Week Low
- ALLT $2.75
- HUMA $1.15
- 52 Week High
- ALLT $10.77
- HUMA $6.77
- Technical
- Relative Strength Index (RSI)
- ALLT 51.18
- HUMA 36.87
- Support Level
- ALLT $7.71
- HUMA $1.43
- Resistance Level
- ALLT $8.10
- HUMA $1.67
- Average True Range (ATR)
- ALLT 0.44
- HUMA 0.15
- MACD
- ALLT 0.09
- HUMA -0.01
- Stochastic Oscillator
- ALLT 59.12
- HUMA 23.32
About ALLT Allot Ltd.
Allot Ltd is a provider of network intelligence and security solutions for service providers and enterprises. The company's solutions are deployed globally for network and application analytics, traffic control and shaping, and network-based security services. The firm's multi-service platforms are deployed by mobile, fixed, and cloud service providers and enterprises. The company has a customer base in Europe, Asia and Oceania, the Americas, the Middle East, and Africa.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.